Postnatal corticosteroids for transient tachypnoea of the newborn
Given the paucity and very low quality of the available evidence (single RCT; N=49), the benefits and harms of postnatal administration of either inhaled or systemic corticosteroids for the management of transient tachypnoea of the newborn, could not be determined.
Source:
Cochrane Database of Systematic Reviews